Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2017-04-25
Summary
Observe the changes of tear volume in dry eye patients after Restasis treatment of 3 months and during 6-month follow-up after discontinuation of study treatment.
Conditions
- Dry Eye
Sponsors & Collaborators
-
Allergan
collaborator INDUSTRY -
University of Miami
lead OTHER
Principal Investigators
-
Jianhua Wang, MD, PhD · University of Miami
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
NCT02121847 ·Status: COMPLETED ·Phase: PHASE4
-
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
NCT02522312 ·Status: COMPLETED
-
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
NCT00553735 ·Status: TERMINATED ·Phase: PHASE4
-
Switching From Restasis to TRYPTYR
NCT07267299 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy
NCT03403023 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction
NCT00705510 ·Status: COMPLETED ·Phase: PHASE4
-
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
NCT00567177 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®
NCT02554981 ·Status: COMPLETED ·Phase: PHASE4
-
Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation
NCT01128049 ·Status: COMPLETED ·Phase: NA
-
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
NCT03597139 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
NCT04091581 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Ocular Comfort With ISTA Tears vs Systane
NCT01650584 ·Status: COMPLETED ·Phase: NA
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
NCT04393441 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
NCT01319773 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
NCT01198782 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
NCT00349440 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT03211351 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00399061 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use
NCT03274999 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
NCT00611403 ·Status: COMPLETED ·Phase: PHASE2